In this study, we demonstrated that TSC, a traditional Chinese medicine that has likewise been effectively used to treat mammary hyperplasia, predominately inhibits ERα-positive breast cancer cell growth, potentially by down-regulating of ERα expression, thus making ERα-positive breast epithelial cells less sensitive to estrogen-induced cell proliferation. The gene discussed is ESR1; the disease is breast carcinoma.